| Literature DB >> 29357358 |
Xiaoying Shen1, Xuemei Zhu1, Yanni Wu2, Yuqiu Zhou3, Li Yang1, Yini Wang1, Qiulan Zheng1, Yinghui Liu2, Shen Cong2, Ningning Xiao1, Qiuli Zhao1.
Abstract
PURPOSE: This study aimed to assess the effects of a psychological intervention programme on the mental stress, coping style and cortisol and IL-2 levels of patients undergoing percutaneous coronary intervention (PCI).Entities:
Mesh:
Year: 2018 PMID: 29357358 PMCID: PMC5777641 DOI: 10.1371/journal.pone.0187745
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1CONSORT 2010 flow diagram.
Contents of intervention sessions.
| Session | Contents | Temporal arrangement |
|---|---|---|
| (a) Organization of a meeting for postoperative and preoperative patients to encourage the preoperative patients to accept the treatment and operation positively and optimistically. | The day of the decision regarding the operation (30–45 min) | |
| Consisted of progressive muscle relaxation, meditation, thought guidance, deep breathing, and massage by a specific counselling expert. | Each morning and afternoon of hospitalization voluntarily, 15–30 min each time | |
| Created a relaxing and warm environment for patients and families and gave them moral encouragement and appropriate daily care. Encouraged patients and families to communicate with each other. | Daily communication with patients and family |
Demographic and clinical characteristics of the participants (N = 60).
| Characteristic | Total | Intervention group (n = 30) | Control group (n = 30) | Pvalue | |
|---|---|---|---|---|---|
| 30 (50.0%) | 16 (53.3%) | 14 (46.7%) | 0.80 | ||
| 30 (50.0%) | 14 (46.7%) | 16 (53.3%) | |||
| 57.6±9.92 | 58.6±10.7 | 56.5±9.2 | 0.41 | ||
| 36 (60.0%) | 18 (60.0%) | 18 (60.0%) | 0.47 | ||
| 13 (21.7%) | 8 (26.7%) | 5 (16.7%) | |||
| 11 (18.3%) | 4 (13.3%) | 7 (23.3%) | |||
| 8.17±1.25 | 8.27±1.37 | 8.06±1.19 | 0.53 | ||
| 5.24±0.54 | 5.23±0.57 | 5.26±0.52 | 0.86 | ||
| 1.97±0.33 | 2.04±0.34 | 1.91±0.30 | 0.14 | ||
| 1.64±0.49 | 1.59±0.51 | 1.68±0.47 | 0.49 | ||
| 2.82±0.43 | 2.86±0.44 | 2.79±0.42 | 0.57 | ||
| 27 (45.0%) | 15 | 12 | 0.44 | ||
| 33 (55.9%) | 15 | 18 | |||
Comparison of SCL-90, MCMQ, IL-2 and cortisol between groups before the intervention.
| Total (n = 60) | Experimental (n = 30) | Control (n = 30) | P value | |
|---|---|---|---|---|
| 192.55±38.06 | 193.87±39.07 | 191.23±37.65 | 0.79 | |
| | 31.40±8.41 | 31.60±8.52 | 31.20±8.45 | 0.86 |
| | 23.45±6.02 | 22.50±5.46 | 24.40±6.47 | 0.22 |
| | 14.77±4.93 | 15.73±5.25 | 13.80±4.46 | 0.13 |
| | 28.15±8.80 | 28.33±9.33 | 27.97±8.39 | 0.87 |
| | 25.73±6.94 | 25.43±6.42 | 26.03±7.51 | 0.74 |
| | 10.85±3.74 | 11.57±3.89 | 10.13±3.49 | 0.14 |
| | 14.43±5.89 | 15.87±6.60 | 13.00±4.77 | 0.06 |
| | 10.13±3.15 | 9.37±2.77 | 10.90±3.36 | 0.06 |
| | 17.85±4.44 | 17.43±4.55 | 18.27±4.36 | 0.47 |
| | 16.13±5.17 | 16.03±4.86 | 16.23±5.55 | 0.88 |
| 48.82±3.68 | 49.50±4.02 | 48.13±3.22 | 0.15 | |
| | 19.97±2.16 | 20.07±2.46 | 19.87±1.83 | 0.72 |
| | 15.42±2.29 | 15.80±2.58 | 15.03±1.92 | 0.20 |
| | 13.25±1.99 | 13.27±2.27 | 13.23±1.72 | 0.95 |
| 30.54±8.80 | 31.54±9.35 | 29.54±8.26 | 0.38 | |
| 443.88±71.49 | 453.43±67.48 | 434.32±75.21 | 0.31 |
Comparison of SCL-90, MCMQ, IL-2 and cortisol between groups after the intervention.
| Experimental (n = 30) | Control (n = 30) | P value | |
|---|---|---|---|
| 132.73±20.60 | 172.57±38.067 | 0.00 | |
| | 19.33±4.84 | 25.97±8.05 | 0.00 |
| | 16.37±3.16 | 22.67±6.25 | 0.00 |
| | 12.50±1.96 | 14.0±5.26 | 0.15 |
| | 18.20±4.70 | 25.63±7.66 | 0.00 |
| | 15.17±3.74 | 21.97±7.02 | 0.00 |
| | 8.13±1.94 | 10.60±3.10 | 0.00 |
| | 11.00±4.06 | 12.77±5.62 | 0.17 |
| | 7.20±0.93 | 8.47±2.56 | 0.02 |
| | 13.67±2.44 | 16.03±3.88 | 0.01 |
| | 11.17±3.36 | 14.47±4.81 | 0.00 |
| 51.03±3.39 | 49.13±3.15 | 0.03 | |
| | 21.70±2.02 | 20.47±1.81 | 0.02 |
| | 15.53±2.40 | 15.17±1.72 | 0.50 |
| | 13.80±1.03 | 13.50±1.46 | 0.36 |
| 35.22±10.52 | 30.02±8.34 | 0.04 | |
| 302.23±79.49 | 442.41±67.60 | 0.00 |
Effect size of experimental and control group subjects’ pre- versus post-intervention assessments.
| experimental group (n = 30) | Control group (n = 30) | |||||
|---|---|---|---|---|---|---|
| Pre-intervention | post-intervention | Cohen’s d | Pre-intervention | post-intervention | Cohen’s d | |
| 193.87±39.07 | 132.73±20.60 | -1.56 | 191.23±37.65 | 172.57±38.067 | -0.50 | |
| | 31.60±8.52 | 19.33±4.84 | -1.44 | 31.20±8.45 | 25.97±8.05 | -0.62 |
| | 22.50±5.46 | 16.37±3.16 | -1.12 | 24.40±6.47 | 22.67±6.25 | -0.27 |
| | 15.73±5.25 | 12.50±1.96 | -0.615 | 13.80±4.46 | 14.0±5.26 | 0.04 |
| | 28.33±9.33 | 18.20±4.70 | -1.09 | 27.97±8.39 | 25.63±7.66 | -0.28 |
| | 25.43±6.42 | 15.17±3.74 | -1.60 | 26.03±7.51 | 21.97±7.02 | -0.54 |
| | 11.57±3.89 | 8.13±1.94 | -0.88 | 10.13±3.49 | 10.60±3.10 | 0.13 |
| | 15.87±6.60 | 11.00±4.06 | -0.73 | 13.00±4.77 | 12.77±5.62 | -0.05 |
| | 9.37±2.77 | 7.20±0.93 | -0.78 | 10.90±3.36 | 8.47±2.56 | -0.72 |
| | 17.43±4.55 | 13.67±2.44 | -0.83 | 18.27±4.36 | 16.03±3.88 | -0.51 |
| | 16.03±4.86 | 11.17±3.36 | -1 | 16.23±5.55 | 14.47±4.81 | -0.32 |
| 49.50±4.02 | 51.03±3.39 | 0.38 | 48.13±3.22 | 49.13±3.15 | 0.31 | |
| | 20.07±2.46 | 21.70±2.02 | 0.66 | 19.87±1.83 | 20.47±1.81 | 0.33 |
| | 15.80±2.58 | 15.53±2.40 | -0.1 | 15.03±1.92 | 15.17±1.72 | 0.07 |
| | 13.27±2.27 | 13.80±1.03 | 0.23 | 13.23±1.72 | 13.50±1.46 | 0.16 |
| 30.61±8.26 | 34.89±10.47 | 0.52 | 31.63±9.34 | 29.08±8.34 | 0.27 | |
| 453.43±67.48 | 302.23±79.49 | 2.24 | 434.32±75.21 | 442.41±67.60 | 0.11 | |
*: Cohen's d = (M2—M1)⁄ SD preintervention; M2 means the mean of post-intervention; M1 means the mean of the Pre-intervention.